Explorer les evidences

27 hThe median time from sample collection to viral load result return by Mentor Mothers was 27.0 h.

KenyaVIH/sidaobservé June-December 2023publié 2026AIDS and behaviorPubMeddocument de 4 observations

2,6 %In scenario 1, transportation time contributed 2.6% to overall turnaround time for HIV viral load monitoring.

KenyaVIH/sidapublié 2024Health policy and planningPubMeddocument de 15 observations

32 clustersThirty-two clusters with shared pre-treatment HIV drug resistance mutations were identified in Kenya.

KenyaVIH/sidapublié 2024The Journal of antimicrobial chemotherapyPubMeddocument de 7 observations

46,7 %The pooled prevalence of abnormal lung function among individuals who completed treatment for pulmonary TB in low- and middle-income countries was 46.7%.

Kenyaabnormal lung function · post-TB lung disease · tuberculosepublié 2022PLOS global public healtheurope_pmcdocument de 11 observationsDOI 10.1371/journal.pgph.0000805

24 %Compared to mean coverage in infants, static coverage at 12 months was exaggerated by 24% for the measles vaccine.

Kenyarougeoleobservé 2010 to 2017publié 2018Vaccineeurope_pmcdocument de 5 observations

4,2 %Among 911 women in the PrEP Implementation of Mothers in Antenatal Care trial in Kenya, 4.2% accepted oral pre-exposure prophylaxis alone.

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 11 observations

50 %Cells from women who are epidemiologically deemed resistant to HIV infection exhibit a 40-60% reduction in endogenous IRF-1.

KenyaVIH/sidapublié 2015Molecular therapy. Nucleic acidseurope_pmcdocument de 2 observations

23 %As of October 2021, 23% of Fahari ya Jamii project-supported HIV clinics in Nairobi and Kajiado Counties were offering cervical cancer screening for women living with HIV.

Kenyacancer du col de l'utérusobservé October 2021publié 2025BMC women's healthPubMeddocument de 8 observations

0,05 prevalence_differenceThe adjusted site-specific prevalence difference for anemia later in pregnancy among Kenyan women with first-trimester malaria was 0.05.

Kenyaanémie · paludismepublié 2024PloS onePubMeddocument de 14 observations

84 %Among 100 pregnant women living with HIV in Western Kenya, 84% reported economic wellbeing as a priority area affected by their HIV status.

KenyaVIH/sidapublié 2022BMC women's healthPubMeddocument de 5 observations

3,6 %HIV prevalence among female sex workers aged 16–20 years in Kenya was 3.6%.

KenyaVIH/sidapublié 2020International journal of STD & AIDSeurope_pmcdocument de 5 observations

Parasite prevalence in school children (PfPR 5to16 ) was obtained from biennial council representative school malaria parasitaemia surveys conducted in 2014–2015 and 2017.

Kenyapaludismeobservé 2014-2015, 2017publié 2020Malaria journaleurope_pmcdocument de 9 observations

85 %Of 107 samples that underwent drug resistance mutation testing, 91 (85%) had major drug resistance mutations.

KenyaVIH/sidapublié 2022The Lancet. Child & adolescent healthPubMeddocument de 12 observations

38 %38% of uncomplicated fevers were taken to a health care facility in Kenya between 2001 and 2002.

Kenyafeverobservé 2001 and 2002publié 2006BMC public healtheurope_pmcdocument de 10 observations

1 110 childrenThere were 1110 children identified with uraemia in the AQUAMAT trial.

Kenyauraemiapublié 2021Malaria journalPubMeddocument de 14 observations

1 000 introductionsMore than 1000 SARS-CoV-2 introductions occurred in Kenya between March 2020 and September 2022.

KenyaCOVID-19observé March 2020 – September 2022publié 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument de 8 observationsDOI 10.1101/2022.10.26.22281446

5,6 %Mortality by 6 months after discharge was 5.6% among children with severe pneumonia in western Kenya.

Kenyapneumonie sévèreobservé 2008 and 2013publié 2023The American journal of tropical medicine and hygienePubMeddocument de 7 observations

6,33 aORAt 6 weeks, high maternal viral load was associated with higher odds of underweight infants (adjusted odds ratio 6.33).

KenyaVIH/sidapublié 2025AIDS and behaviorPubMeddocument de 8 observations

18,7 %In scenario 1, waiting time at the testing site accounted for 18.7% of total turnaround time for HIV viral load monitoring.

KenyaVIH/sidapublié 2024Health policy and planningPubMeddocument de 15 observations

2,17 %Seventeen Plasmodium falciparum isolates from Kenya carried synonymous k13 mutations, representing 2.17% of isolates.

Kenyapaludismeobservé 2018–2022publié 2024Malaria journalPubMeddocument de 7 observations

50,5 %Overall treatment uptake rate was 50.5% among 551 women who tested positive for high-risk HPV in western Kenya.

Kenyahigh-risk HPVpublié 2022JMIR public health and surveillancePubMeddocument de 8 observations

In randomised controlled trials in Kenya and Uganda, incident HIV infections were eliminated when long-acting cabotegravir was included as an option in the dynamic choice HIV prevention intervention.

Kenya · OugandaVIH/sidapublié 2025The lancet. HIVPubMeddocument de 11 observations

3,4 aORPatients with TB symptoms were over three times as likely to have a new HIV diagnosis in private not-for-profit facilities compared to those in government facilities (adjusted odds ratio (aOR) 3.40; 95% CI = 1.96–5.90).

Kenyatuberculose · VIH/sidaobservé 2018publié 2022International journal of STD & AIDSPubMeddocument de 4 observations

96 %Among HIV positive mothers, knowledge regarding exclusive breastfeeding for HIV-exposed infants was 96% in the BFCI intervention arm and 100% in the control arm.

KenyaVIH/sidapublié 2020International breastfeeding journalPubMeddocument de 6 observations

56 %At 50 parasites/µL, the sensitivity of conventional rapid diagnostic test (cRDT) was 56%.

Kenyapaludismepublié 2022The Journal of infectious diseasesPubMeddocument de 13 observations